Results summary | View all lists in GO:BiolProc | View all genes in D07X.profile.u50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.86-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
211082_X_AT | MARK2 | D | P | S | MAP/microtubule affinity-regulating kinase 2 | ||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
200878_AT | EPAS1 | D | X | R | S | endothelial PAS domain protein 1 | |||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
208960_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
44783_S_AT | HEY1 | D | R | hairy/enhancer-of-split related with YRPW motif 1 | |||||||||
206127_AT | ELK3 | D | X | R | S | ELK3, ETS-domain protein (SRF accessory protein 2) |